The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 3%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (11 analysts) rates it hold, with a mean price target of $39.
CNX Resources Corporation
CNX · the NYSE · USD · Market cap $5.2B · 390 employees
CNX Resources Corporation, an independent natural gas and midstream company, engages in the acquisition, exploration, development, and production of natural gas properties in the Appalachian Basin.
PASS · Titan Ethical · score 70.0Price as of 19 Nov 2026Daily close, not a live quote
Screened 2026-11-19 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price35.14 USD at the 19 Nov 2026 close
- Our value readOvervalued vs our fair value, as of 19 Nov 2026
- Our regime readAccumulation, as of 17 Nov 2026
- Ethical screenPasses, score 70.0 out of 100
- OptionsOpen interest leans heavily to calls (put/call 0.26)
- Last reviewed19 Nov 2026 (1 day ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $30.60 to $36.04, base estimate $31.34 (screen dated 2026-11-19).
- Trend Accumulation
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.26, read 2026-11-19
- Ethical passes the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its accumulation label.
CNX Resources Corporation holds its Accumulation at $35.14. The statistical read favours the sellers, held for 446 days.
| Phase | Accumulation |
| Quantitative state | The statistical read favours the sellers, held for 446 days |
| Price at the screen | $35.14 |
| Valuation | 5.92 trailing · 8.58 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 0.59 |
Five Screens: CNX's Results
PASS. All five recorded results clear their limits.
| Test | Figure | Limit | Status |
|---|---|---|---|
| Business activity | Permissible | Permissible core business | Pass |
| Debt load | 28.64% | Below 33% | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Pass |
| Receivables | 2.92% | Below 49% | Pass |
| Revenue purity | 0.05% | Below 5% | Pass |
Definitions, sources and threshold rules: ticker values-screen methodology.
The Ethical ReadWhy It Clears, in Plain English
CNX Resources clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 29%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when CNX's ethical verdict changes
Today CNX passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Overvalued vs our fair value, as of 19 Nov 2026: it trades above our $31.34 fair value estimate.
Model construction and limits: fair-value methodology.
Fair value range in USD, drawn from the 2026-11-19 screen. The gold marker is the market price at the same screen. The price runs 12.1% above the base estimate.
Third-party analyst targets: 12 covering, consensus Hold. The average target sits +8% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere our models see it going: fair-value estimate $31.34, with a range of $30.60 to $36.04, dated to the 2026-11-19 screen.
How our estimate and third-party targets differ.
The Business, in Plain WordsAppalachian gas producer at a tempting low multiple
Picture a rig operator in Pennsylvania watching winter demand spike and prices jump. CNX Resources shows revenue up 28 percent, a 53 percent profit margin and 28 percent return on equity, all at a forward multiple of just 8.1 times. The shares sit 6 percent below our fair value with analysts clustered around a 36 dollar median target, so the headline numbers look attractive on paper.
Yet the business sits squarely inside a cyclical industry where earnings peak when gas prices surge and collapse when they fall. A low multiple on inflated profits is not a bargain; it is often the warning sign that margins will compress and capital spending will rise again once the cycle turns.
The ethical screen is clear and the balance sheet carries no obvious red flags, but the value-trap risk remains the dominant factor. We pass.
Analysis, not advice.
| Forward P/E | 8.6xvery cheap relative to earnings |
| Trailing P/E | 5.9xvery cheap relative to earnings |
| EPS, trailing | 6.11 |
| EPS, forward | 4.22 |
| Revenue growth | -7.0%revenue is shrinking |
| Profit margin | 43.4%highly profitable on every dollar of sales |
| Return on equity | 20.4%an exceptional return on shareholder capital |
| FCF yield | 4.59% |
| Debt to equity | 0.50moderate, manageable leverage |
| Current ratio | 1.08adequate liquidity, worth monitoring |
| Beta | 0.59steadier than the market |
| Short interest, float | 0.17% |
| 52-week range | 30.78 - 43.62 |
| Market cap | $5.2B |
| Employees | 390 |
Metric definitions and interpretation rules: ticker-page methodology.
Every Entry, As Written
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 3%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (11 analysts) rates it hold, with a mean price target of $39.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 5.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 3%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (11 analysts) rates it hold, with a mean price target of $39.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 6.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 3%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (11 analysts) rates it hold, with a mean price target of $39. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 3%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (11 analysts) rates it hold, with a mean price target of $39. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 3%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (11 analysts) rates it hold, with a mean price target of $39. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 3%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (11 analysts) rates it hold, with a mean price target of $39. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 3%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (11 analysts) rates it hold, with a mean price target of $39. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 3%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (11 analysts) rates it hold, with a mean price target of $39. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 3%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (11 analysts) rates it hold, with a mean price target of $39. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Occidental Petroleum Q3 Earnings Beat Estimates on Strong Oil Prices Yahoo Finance · 8d ago
- Devon Q3 Earnings Outpace Estimates on Higher Output, Revenues Miss Yahoo Finance · 14d ago
- Plains All American Q3 Earnings Lag Estimates, Sales Increase Y/Y Yahoo Finance · 14d ago
- Murphy Oil Q3 Earnings Beat Estimates on Strong Prices & Lower Costs Yahoo Finance · 15d ago
- National Fuel Gas Q4 Earnings Outpace Estimates, Revenues Increase Y/Y Yahoo Finance · 15d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $36.11 | -7.6% | · | $924 | -7.6% |
| 2 months | $39.28 | -15.1% | · | $849 | -15.1% |
| 3 months | $41.11 | -18.9% | · | $811 | -18.9% |
| 6 months | $40.20 | -17.0% | · | $830 | -17.0% |
| 1 year | $32.29 | +3.3% | · | $1,033 | +3.3% |
| 2 years | $26.17 | +27.4% | · | $1,274 | +27.4% |
| 3 years | $16.86 | +97.8% | · | $1,978 | +97.8% |
| 5 years | $14.75 | +126.1% | · | $2,261 | +126.1% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever CNX does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.